Linezolid and tiamulin cross-resistance in Staphylococcus aureus mediated by point mutations in the peptidyl transferase center

Antimicrobial Agents and Chemotherapy
Keith MillerIan Chopra

Abstract

Oxazolidinone and pleuromutilin antibiotics are currently used in the treatment of staphylococcal infections. Although both antibiotics inhibit protein synthesis and have overlapping binding regions on 23S rRNA, the potential for cross-resistance between the two classes through target site mutations has not been thoroughly examined. Mutants of Staphylococcus aureus resistant to linezolid were selected and found to exhibit cross-resistance to tiamulin, a member of the pleuromutilin class of antibiotics. However, resistance was unidirectional because mutants of S. aureus selected for resistance to tiamulin did not exhibit cross-resistance to linezolid. This contrasts with the recently described PhLOPS(A) phenotype, which confers resistance to both oxazolidinones and pleuromutilins. The genotypes responsible for the phenotypes we observed were examined. Selection with tiamulin resulted in recovery of mutants with changes in the single-copy rplC gene (Gly155Arg, Ser158Leu, or Arg149Ser), whereas selection with linezolid led to recovery of mutants with changes (G2576U in 23S rRNA) in all five copies of the multicopy operon rrn. In contrast, cross-resistance to linezolid was exhibited by tiamulin-resistant mutants generated in a sing...Continue Reading

References

Jan 1, 1992·The Journal of Antimicrobial Chemotherapy·I Chopra, K Hacker
Sep 1, 1982·Journal of Bacteriology·A BöckG Högenauer
May 1, 2001·The Journal of Antimicrobial Chemotherapy·A J O'NeillI Chopra
May 25, 2001·Antimicrobial Agents and Chemotherapy·A J O'Neill, I Chopra
Jun 1, 2002·The Journal of Antimicrobial Chemotherapy·Keith MillerIan Chopra
Dec 21, 2002·The Journal of Antimicrobial Chemotherapy·Peter WilsonM Robbins
Aug 26, 2003·Antimicrobial Agents and Chemotherapy·Jacob BøslingKatherine S Long
Mar 30, 2006·Antimicrobial Agents and Chemotherapy·Katherine S LongBirte Vester
Jun 28, 2006·Antimicrobial Agents and Chemotherapy·Ronald N JonesJames E Ross
Oct 27, 2006·Antimicrobial Agents and Chemotherapy·Stephen RittenhouseDavid Payne

❮ Previous
Next ❯

Citations

Dec 23, 2008·Proceedings of the National Academy of Sciences of the United States of America·Chen DavidovichAda Yonath
Jun 24, 2008·The Journal of Antimicrobial Chemotherapy·N WoodfordD M Livermore
Sep 16, 2010·The Journal of Antimicrobial Chemotherapy·Rodrigo E MendesRonald N Jones
Oct 21, 2011·The Journal of Antimicrobial Chemotherapy·Tomasz HauschildStefan Schwarz
Dec 17, 2008·Antimicrobial Agents and Chemotherapy·Vandana KaliaV Samuel Raj
Oct 7, 2009·Antimicrobial Agents and Chemotherapy·Jeffrey B LockeKaren Joy Shaw
Dec 7, 2011·Antimicrobial Agents and Chemotherapy·Katherine S Long, Birte Vester
May 24, 2013·Journal of Clinical Microbiology·Rodrigo E MendesRonald N Jones
Jun 2, 2014·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Rodrigo E MendesRonald N Jones
May 6, 2014·The Journal of Antimicrobial Chemotherapy·Engeline van DuijkerenKarolina Törneke
Nov 26, 2009·Critical Reviews in Biochemistry and Molecular Biology·Daniel N Wilson
Oct 16, 2015·Proceedings of the National Academy of Sciences of the United States of America·Zohar EyalAda Yonath
Dec 24, 2011·Annals of the New York Academy of Sciences·Rodger Novak
Jan 9, 2015·The Journal of Antimicrobial Chemotherapy·Christopher P RandallAlex J O'Neill
Oct 19, 2016·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Caroline RouardNadège Bourgeois-Nicolaos
Sep 19, 2014·Perspectives in Medicinal Chemistry·Richard J Fair, Yitzhak Tor
Apr 8, 2015·Antimicrobial Agents and Chemotherapy·Rasmus N KlitgaardBirte Vester
Jul 25, 2019·Future Microbiology·Whitney Perry, Yoav Golan
Oct 16, 2016·Cold Spring Harbor Perspectives in Medicine·Susanne Paukner, Rosemarie Riedl
Nov 3, 2016·Cold Spring Harbor Perspectives in Medicine·Stefan SchwarzBirte Vester
Jun 13, 2020·Antibiotics·Erin E KilleavySteven T Gregory
Mar 10, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Sang-Hun OhJin-Hwan Kwak
Feb 9, 2021·Critical Reviews in Food Science and Nutrition·Alberto Gonçalves EvangelistaFernando Bittencourt Luciano

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.